Take Action:

1. Stay Informed – sign up for NJ Vaccine Science action alerts via email, check our Advocacy Home page and our Blog for action items, follow us on Twitter, and like us on Facebook.


2. Call and Email your Senator and Assemblymembers – ask them to oppose bill S902/A969. Use this link to find your representatives’ phone number and send them a message.


3. Call and Email the Bill Sponsors: Senate President Sweeney: sensweeney@njleg.org / 856-251-9801; Assemblyman Conway  asmconway@njleg.org / (856) 461-3997


If you live in Legislative District 11 sign our D11 Petition to protect NJ’s RE. 

Contact NJ Vaccine Science at:


All information, data and material contained, presented, or provided here is for general information purposes only and is not to be construed as reflecting the knowledge or opinions of the publisher, and is not to be construed or intended as providing medical or legal advise. The decision to vaccinate and how you implement that decision is yours and yours alone. You are encouraged to consult with your medical professional and legal adviser.

THE GREATER GOOD PART III: Current vaccination practices for chickenpox, shingles, rotavirus, and MMR do not protect the immuno-compromised.

The greater good and the protection of the immunocompromised is often cited as the primary rationale for mandatory vaccination. It is currently be used as motivation to remove NJ’s Religious Exemption. This idea is untenable. We’ve addresses that a number of vaccines do not claim to protect the greater good (Part I). We’ve also address how vaccines have yet to provide herd immunity due to primary (low responders) and secondary (early waners) vaccine failure (Part II).

Here in Part III we examine how current vaccination practices do not protect the immuno-compromised for the live chickenpox, shingles, rotavirus, and MMR vaccines. Any time the safety precautions listed on the vaccines label are not followed, the greater good and immunocompromised are put at risk due to live vaccines shedding.   

  • Chicken Pox: (https://www.merck.com/product/usa/pi_circulars/v/varivax/varivax_pi.pdf)  The vaccine label states: “Due to the concern for transmission of vaccine virus, vaccine recipients should attempt to avoid whenever possible close association with susceptible high-risk individuals for up to six weeks following vaccination with VARIVAX. Susceptible high-risk individuals include:
    • Immunocompromised individuals;
    • Pregnant women without documented history of varicella or laboratory evidence of prior infection;
    • Newborn infants of mothers without documented history of varicella or laboratory evidence of prior infection and all newborn infants born at <28 weeks gestation regardless of maternal varicella immunity.
  • Furthermore, the vaccine label states “post-marketing experience suggests that transmission of vaccine virus may occur rarely between healthy vaccinees who develop a varicella-like rash and healthy susceptible contacts.”
  • Furthermore the insert states “One clinical trial demonstrated that vaccinees transmit vaccine virus to healthy seronegative contacts [see Clinical Pharmacology].”

Sign Up for Email Action Alerts

* indicates required